BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Di Marco M, Carloni R, De Lorenzo S, Grassi E, Palloni A, Formica F, Brocchi S, Filippini DM, Golfieri R, Brandi G. Long-term survival of two patients with recurrent pancreatic acinar cell carcinoma treated with radiofrequency ablation: A case report. World J Clin Cases 2020; 8(7): 1241-1250 [PMID: 32337198 DOI: 10.12998/wjcc.v8.i7.1241]
URL: https://www.wjgnet.com/2307-8960/full/v8/i7/1241.htm
Number Citing Articles
1
Shuhei Yamada, Haruka Motegi, Yoshiki Kurihara, Tomonori Shimbo, Isao Kikuchi, Toshiki Wakabayashi, Tsutomu Sato. A resected case of acinar cell carcinoma of the pancreas with liver metastasis following chemotherapy using modified FOLFIRINOXSurgical Case Reports 2023; 9(1) doi: 10.1186/s40792-023-01729-1
2
Capecitabine/gemcitabine/oxaliplatinReactions Weekly 2020; 1803(1): 70 doi: 10.1007/s40278-020-78264-4
3
Ekaterina Petrova, Joachim Wellner, Anne K. Nording, Rüdiger Braun, Kim C. Honselmann, Louisa Bolm, Richard Hummel, Monika Klinkhammer-Schalke, Sylke Ruth Zeissig, Kees Kleihues van Tol, Sylvia Timme-Bronsert, Peter Bronsert, Sergey Zemskov, Tobias Keck, Ulrich Friedrich Wellner. Survival Outcome and Prognostic Factors for Pancreatic Acinar Cell Carcinoma: Retrospective Analysis from the German Cancer Registry GroupCancers 2021; 13(23): 6121 doi: 10.3390/cancers13236121
4
Katsuhito Teramatsu, Nao Fujimori, Masatoshi Murakami, Sho Yasumori, Kazuhide Matsumoto, Kohei Nakata, Masafumi Nakamura, Yutaka Koga, Yoshinao Oda, Yoshihiro Ogawa. Pathological complete response with FOLFIRINOX therapy for recurrence of pancreatic acinar cell carcinomaClinical Journal of Gastroenterology 2024; 17(4): 776 doi: 10.1007/s12328-024-01983-2